These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 30293667

  • 1. ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death.
    Porthan K, Kenttä T, Niiranen TJ, Nieminen MS, Oikarinen L, Viitasalo M, Hernesniemi J, Jula AM, Salomaa V, Huikuri HV, Albert CM, Tikkanen JT.
    Int J Cardiol; 2019 Feb 01; 276():125-129. PubMed ID: 30293667
    [Abstract] [Full Text] [Related]

  • 2. Peguero-Lo Presti criteria for the diagnosis of left ventricular hypertrophy: A systematic review and meta-analysis.
    Yu Z, Song J, Cheng L, Li S, Lu Q, Zhang Y, Lin X, Liu D.
    PLoS One; 2021 Feb 01; 16(1):e0246305. PubMed ID: 33513186
    [Abstract] [Full Text] [Related]

  • 3. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM.
    J Electrocardiol; 2009 Feb 01; 42(6):584-8. PubMed ID: 19631946
    [Abstract] [Full Text] [Related]

  • 4. Short-term repeatability of the peguero-lo presti electrocardiographic left ventricular hypertrophy criteria.
    Drager D, Soliman EZ, Meyer ML, Zhang ZM, Alonso A, Heiss G, Whitsel EA.
    Ann Noninvasive Electrocardiol; 2021 May 01; 26(3):e12829. PubMed ID: 33591619
    [Abstract] [Full Text] [Related]

  • 5. Peguero-Lo Presti criteria for diagnosis of left ventricular hypertrophy: a cardiac magnetic resonance validation study.
    Guerreiro C, Azevedo P, Ladeiras-Lopes R, Ferreira N, Barbosa AR, Faria R, Almeida J, Primo J, Melica B, Braga P.
    J Cardiovasc Med (Hagerstown); 2020 Jun 01; 21(6):437-443. PubMed ID: 32251077
    [Abstract] [Full Text] [Related]

  • 6. Automatic ECG-based detection of left ventricular hypertrophy and its predictive value in haemodialysis patients.
    Letz T, Hörandtner C, Braunisch MC, Gundel P, Matschkal J, Bachler M, Lorenz G, Körner A, Schaller C, Lattermann M, Holzinger A, Heemann U, Wassertheurer S, Schmaderer C, Mayer CC.
    Physiol Meas; 2023 Jul 10; 44(7):. PubMed ID: 37336235
    [Abstract] [Full Text] [Related]

  • 7. Accuracy of the novel Peguero Lo-Presti criterion for electrocardiographic detection of left ventricular hypertrophy in a black African population.
    Nyaga UF, Boombhi J, Menanga A, Mokube M, Ndomo Mevoula CS, Kingue S, Noubiap JJ.
    J Clin Hypertens (Greenwich); 2021 Jun 10; 23(6):1186-1193. PubMed ID: 33783138
    [Abstract] [Full Text] [Related]

  • 8. Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients.
    Snelder SM, van de Poll SWE, de Groot-de Laat LE, Kardys I, Zijlstra F, van Dalen BM.
    Clin Cardiol; 2020 May 10; 43(5):483-490. PubMed ID: 31990994
    [Abstract] [Full Text] [Related]

  • 9. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN, Devereux RB, Okin PM.
    J Electrocardiol; 2014 May 10; 47(5):630-5. PubMed ID: 25052475
    [Abstract] [Full Text] [Related]

  • 10. A meta-analytic evaluation of the diagnostic accuracy of the electrocardiographic Peguero-Lo Presti criterion for left ventricular hypertrophy.
    Noubiap JJ, Agbaedeng TA, Nyaga UF, Nkoke C, Jingi AM.
    J Clin Hypertens (Greenwich); 2020 Jul 10; 22(7):1145-1153. PubMed ID: 32608577
    [Abstract] [Full Text] [Related]

  • 11. Electrocardiographic parameters of left ventricular hypertrophy and prediction of mortality in hemodialysis patients.
    Braunisch MC, Gundel P, Werfel S, Mayer CC, Bauer A, Haller B, Günthner R, Lorenz G, Angermann S, Matschkal J, Schaller C, Holzmann-Littig C, Kemmner S, Mann J, Krieter A, Renders L, Wassertheurer S, Schmidt G, Heemann U, Malik M, Schmaderer C.
    J Nephrol; 2022 Jan 10; 35(1):233-244. PubMed ID: 34014512
    [Abstract] [Full Text] [Related]

  • 12. Influence of relative wall thickness on electrocardiographic voltage measures in left ventricular hypertrophy: a novel factor contributing to poor diagnostic accuracy.
    Ye N, Sun GZ, Zhou Y, Wu SJ, Sun YX.
    Postgrad Med; 2020 Mar 10; 132(2):141-147. PubMed ID: 31900004
    [Abstract] [Full Text] [Related]

  • 13. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease.
    Agarwal R, Light RP.
    Clin J Am Soc Nephrol; 2011 Mar 10; 6(3):528-36. PubMed ID: 21088286
    [Abstract] [Full Text] [Related]

  • 14. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlöf B, LIFE Study Group.
    Hypertension; 2000 Jan 10; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [Abstract] [Full Text] [Related]

  • 15. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    JAMA; 2004 Nov 17; 292(19):2343-9. PubMed ID: 15547161
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
    Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Porcellati C.
    J Am Coll Cardiol; 1998 Feb 17; 31(2):383-90. PubMed ID: 9462583
    [Abstract] [Full Text] [Related]

  • 17. Peguero Electrocardiographic Left Ventricular Hypertrophy Criteria and Risk of Mortality.
    Afify HMA, Waits GS, Ghoneum AD, Cao X, Li Y, Soliman EZ.
    Front Cardiovasc Med; 2018 Feb 17; 5():75. PubMed ID: 30013976
    [Abstract] [Full Text] [Related]

  • 18. Detection of Left Ventricular Hypertrophy Using Bayesian Additive Regression Trees: The MESA.
    Sparapani R, Dabbouseh NM, Gutterman D, Zhang J, Chen H, Bluemke DA, Lima JAC, Burke GL, Soliman EZ.
    J Am Heart Assoc; 2019 Mar 05; 8(5):e009959. PubMed ID: 30827132
    [Abstract] [Full Text] [Related]

  • 19. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES.
    Am Heart J; 2010 May 05; 159(5):833-40. PubMed ID: 20435193
    [Abstract] [Full Text] [Related]

  • 20. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J.
    Clin Exp Hypertens; 2010 May 05; 32(3):145-53. PubMed ID: 20504121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.